Slowly digestible, sustained-type energy supplying agent

US10702545B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10702545-B2
Application numberUS-201515512704-A
CountryUS
Kind codeB2
Filing dateSep 18, 2015
Priority dateSep 22, 2014
Publication dateJul 7, 2020
Grant dateJul 7, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An object of the present invention is to provide a carbohydrate-derived energy supplying agent having slow digestibility and sustained digestibility functions. According to the present invention, there is provided a slowly digestible, sustained-type energy supplying agent comprising a saccharide composition which satisfies the following (A), (B), (C), and (D): (A) a percentage of α-1,6 bonds relative to all glycosidic bonds is 60% or more; (B) a content of saccharides having a degree of polymerization of 1 and 2 relative to all saccharides is 9 mass % or less; (C) a content of saccharides having a degree of polymerization within a range of 3 to 30 relative to all saccharides is 41 mass % or more; and (D) a content of saccharides having a degree of polymerization of 31 or more relative to all saccharides is 50 mass % or less.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for energy supply to a mammal, which comprises feeding or administering to the mammal a saccharide composition, wherein said saccharide composition is a dextran degradation product or a fractionated product thereof, or a dextran-producing enzyme reaction product or a fractionated product thereof, which satisfies the following (A), (B), (C), (D), and (E): (A) a percentage of α-1,6 bonds relative to all glycosidic bonds being 60% or more; (B) a content of saccharides having a degree of polymerization of 1 and 2 relative to all saccharides being 9 mass % or less; (C) a content of saccharides having a degree of polymerization within a range of 3 to 30 relative to all saccharides being 41 mass % or more; (D) a content of saccharides having a degree of polymerization of 31 or more relative to all saccharides being 40 mass % or less; and (E) a content of saccharides having a degree of polymerization within a range of 10 to 30 relative to all saccharides being 20 mass % or more, and wherein the saccharide composition is (i) slowly digestible and (ii) has a slow change in blood glucose levels upon intake. 2. The method according to claim 1 , wherein the saccharide composition comprises 3 mass % or more of saccharides having a degree of polymerization within a range of 3 to 9 relative to all saccharides. 3. The method according to claim 1 , wherein the saccharide composition comprises 30 mass % or more of saccharides having a degree of polymerization within a range of 10 to 30 relative to all saccharides. 4. The method according to claim 1 , wherein, in the above (A), (A-1) the percentage of α-1,6 bonds relative to all glycosidic bonds is 90% or more. 5. The method according to claim 1 , wherein, in the above (A), (A-2) the percentage of α-1,6 bonds relative to all glycosidic bonds is 60 to 99%, and a percentage of α-1,4 bonds relative to glycosidic bonds other than the α-1,6 bonds is 80% or more. 6. The method according to claim 1 , wherein the mammal is a human. 7. The method according to claim 6 , wherein the human is a diabetic patient. 8. The method according to claim 1 , wherein the saccharide composition is part of a food or beverage product. 9. A method for treating a disease or a symptom for which slowing a change in blood glucose level is therapeutically effective, comprising feeding or administering to a mammal a saccharide composition, wherein said saccharide composition is a dextran degradation product or a fractionated product thereof, or a dextran-producing enzyme reaction product or a fractionated product thereof, which satisfies the following (A), (B), (C), (D) and (E): (A) a percentage of α-1,6 bonds relative to all glycosidic bonds being 60% or more; (B) a content of saccharides having a degree of polymerization of 1 and 2 relative to all saccharides being 9 mass % or less; (C) a content of saccharides having a degree of polymerization within a range of 3 to 30 relative to all saccharides being 41 mass % or more; (D) a content of saccharides having a degree of polymerization of 31 or more relative to all saccharides being 50 mass % or less; and (E) a content of saccharides having a degree of polymerization within a range of 10 to 30 relative to all saccharides being 20 mass % or more, and wherein the saccharide composition is (i) slowly digestible and (ii) has a slow change in blood glucose levels upon intake. 10. The method according to claim 9 , wherein the saccharide composition comprises 3 mass % or more of saccharides having a degree of polymerization within a range of 3 to 9 relative to all saccharides. 11. The method according to claim 9 , wherein the saccharide composition comprises 30 mass % or more of saccharides having a degree of polymerization within a range of 10 to 30 relative to all saccharides. 12. The method according to claim 9 , wherein, in the above (A), (A-1) the percentage of α-1,6 bonds relative to all glycosidic bonds is 90% or more. 13. The method according to claim 9 , wherein, in the above (A), (A-2) the percentage of α-1,6 bonds relative to all glycosidic bonds is 60 to 99%, and a percentage of α-1,4 bonds relative to glycosidic bonds other than the α-1,6 bonds is 80% or more. 14. The method according to claim 9 , wherein the saccharide composition is part of a food or beverage product.

Assignees

Inventors

Classifications

  • Disaccharides, e.g. lactose, lactulose (lactobionic acid A61K31/7032) · CPC title

  • for hyperglycaemia, e.g. antidiabetics · CPC title

  • Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages · CPC title

  • A61K31/721Primary

    Dextrans · CPC title

  • Dextran; Derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10702545B2 cover?
An object of the present invention is to provide a carbohydrate-derived energy supplying agent having slow digestibility and sustained digestibility functions. According to the present invention, there is provided a slowly digestible, sustained-type energy supplying agent comprising a saccharide composition which satisfies the following (A), (B), (C), and (D): (A) a percentage of α-1,6 bonds re…
Who is the assignee on this patent?
Japan Maize Prod, Morinaga Milk Industry Co Ltd, Nihon Shokuhin Co Ltd
What technology area does this patent fall under?
Primary CPC classification A61K31/721. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).